117 related articles for article (PubMed ID: 15821205)
1. Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients.
Kadowaki M; Demura Y; Mizuno S; Uesaka D; Ameshima S; Miyamori I; Ishizaki T
Chest; 2005 Apr; 127(4):1276-82. PubMed ID: 15821205
[TBL] [Abstract][Full Text] [Related]
2. Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
Kohno S; Yanagihara K; Yamamoto Y; Tokimatsu I; Hiramatsu K; Higa F; Tateyama M; Fujita J; Kadota J
J Infect Chemother; 2013 Dec; 19(6):1035-41. PubMed ID: 23695232
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of azithromycin in aspiration pneumonia: a prospective observational study.
Marumo S; Teranishi T; Higami Y; Koshimo Y; Kiyokawa H; Kato M
BMC Infect Dis; 2014 Dec; 14():685. PubMed ID: 25491126
[TBL] [Abstract][Full Text] [Related]
4. Retrospective investigation of the clinical effects of tazobactam/piperacillin and sulbactam/ampicillin on aspiration pneumonia caused by Klebsiella pneumoniae.
Tsukada H; Sakai K; Cho H; Kimura Y; Tetsuka T; Nakajima H; Ito K
J Infect Chemother; 2012 Oct; 18(5):715-21. PubMed ID: 22460828
[TBL] [Abstract][Full Text] [Related]
5. Peritonsillar abscess: a comparison of outpatient i.m. clindamycin and inpatient i.v. ampicillin/sulbactam following needle aspiration.
Ozbek C; Aygenc E; Unsal E; Ozdem C
Ear Nose Throat J; 2005 Jun; 84(6):366-8. PubMed ID: 16075861
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial.
Hamao N; Ito I; Konishi S; Tanabe N; Shirata M; Oi I; Tsukino M; Matsumoto H; Yasutomo Y; Kadowaki S; Hirai T
BMC Pulm Med; 2020 Jun; 20(1):160. PubMed ID: 32503515
[TBL] [Abstract][Full Text] [Related]
7. [Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].
Ishibashi T; Harada Y; Takamoto M; Ebihara M; Sugiyama M; Shimazu K; Iwanaga T; Kishikawa R; Makie T; Tsurutani H; Kisanuki K; Mitsuno T; Hirota N; Furuno T; Hiraoka T; Tsumori Y; Matsuura Y; Namba K; Oe T; Inuyama M; Chifu S; Fukunaga H; Ueno Y; Matsukizono K; Genka K
Jpn J Antibiot; 1998 Dec; 51(12):746-58. PubMed ID: 10077773
[TBL] [Abstract][Full Text] [Related]
8. Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess.
Allewelt M; Schüler P; Bölcskei PL; Mauch H; Lode H;
Clin Microbiol Infect; 2004 Feb; 10(2):163-70. PubMed ID: 14759242
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: a multicenter, open-label, uncontrolled study.
Kohno S; Tateda K; Mikamo H; Kadota J; Niki Y; Itamura R
J Infect Chemother; 2015 Mar; 21(3):182-8. PubMed ID: 25533886
[TBL] [Abstract][Full Text] [Related]
10. Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A
J Pediatr Hematol Oncol; 2009 Apr; 31(4):270-3. PubMed ID: 19346879
[TBL] [Abstract][Full Text] [Related]
11. Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single-center retrospective observational study.
Suzuki T; Sugiyama E; Nozawa K; Tajima M; Takahashi K; Yoshii M; Suzuki H; Sato VH; Sato H
Pharmacol Res Perspect; 2021 Apr; 9(2):e00746. PubMed ID: 33764686
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of prophylactic administration of SBT/ABPC for preventing surgical site infection in elderly patients undergoing colorectal surgery.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Yamaki S; Asao T; Kuwano H
Hepatogastroenterology; 2009; 56(91-92):656-8. PubMed ID: 19621674
[TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone versus ampicillin/sulbactam for the treatment of aspiration-associated pneumonia in adults.
Hasegawa S; Shiraishi A; Yaegashi M; Hosokawa N; Morimoto K; Mori T
J Comp Eff Res; 2019 Nov; 8(15):1275-1284. PubMed ID: 31736321
[No Abstract] [Full Text] [Related]
14. The efficacy of prophylactic administration of SBT/ABPC for preventing surgical site infection in elderly patients undergoing colorectal surgery.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Yamaki S; Asao T; Kuwano H
Hepatogastroenterology; 2009; 56(93):992-4. PubMed ID: 19760927
[TBL] [Abstract][Full Text] [Related]
15. Cefepime/clindamycin vs. ceftriaxone/clindamycin for the empiric treatment of poisoned patients with aspiration pneumonia.
Talaie H; Jabari HR; Shadnia S; Pajouhmand A; Nava-Ocampo AA; Youssefi M
Acta Biomed; 2008 Aug; 79(2):117-22. PubMed ID: 18788506
[TBL] [Abstract][Full Text] [Related]
16. [Sulbactam/ampicillin in comparison with cefuroxime for infections of the lower respiratory tract. Results of a prospective, randomized comparative study].
Schwigon CD; Cuhorst R; Gabor M; Zinndorf J; Springsklee M
Med Klin (Munich); 1993 Jan; 88(1):16-20. PubMed ID: 8437527
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of meropenem for the treatment of aspiration pneumonia in elderly patients.
Tokuyasu H; Harada T; Watanabe E; Okazaki R; Touge H; Kawasaki Y; Shimizu E
Intern Med; 2009; 48(3):129-35. PubMed ID: 19182422
[TBL] [Abstract][Full Text] [Related]
18. Treatment of intra-abdominal infections: cost comparison of ampicillin/sulbactam and clindamycin/gentamicin.
Chin A; Gill MA; Ito MK; Yellin AE; Berne TV; Heseltine PN; Appleman MD
Hosp Formul; 1990 Mar; 25(3):295-6, 303-5. PubMed ID: 10103837
[TBL] [Abstract][Full Text] [Related]
19. An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.
Todisco T; Dal Farra F; Ciliberti G; Pirina P; Guelfi R; Serra G; Paris R; Mancuso I; Cepparulo M
J Chemother; 2008 Apr; 20(2):225-32. PubMed ID: 18467250
[TBL] [Abstract][Full Text] [Related]
20. Lower Body Mass Index is a Risk Factor for In-Hospital Mortality of Elderly Japanese Patients Treated with Ampicillin/sulbactam.
Miura M; Kuwahara A; Tomozawa A; Omae N; Yamamori M; Kadoyama K; Sakaeda T
Int J Med Sci; 2016; 13(10):749-753. PubMed ID: 27766023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
